Home » Topics » Regulatory

Regulatory
RSS

Label expansion recommended for Photofrin in U.S.

Sep. 4, 1998

FDA clears Intron A for pediatric chronic hepatitis B

Sep. 4, 1998

FDA approves Gemzar for first-line treatment of non-small cell lung cancer

Sep. 4, 1998

Nolvadex recommended for approval in U.S., to be copromoted by Zeneca and Roche

Sep. 3, 1998

Lamotrigine approved for new indication in the U.S.: Lennox-Gastaut syndrome

Sep. 2, 1998

FDA approves first vaccine for prevention of rotaviral disease

Sep. 1, 1998

FDA grants first approval for an antisense drug

Aug. 31, 1998

Canadian authorities approve use of Fragmin in treatment of heart disease

Aug. 31, 1998

Hoechst Marion Roussel and 3M file NDA for QVAR

Aug. 28, 1998

CIBIS-II study results confirm benefits of beta-blockade in heart failure

Aug. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...